Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2025-12-25 @ 12:40 AM
NCT ID:
NCT00575367
Eligibility Criteria:
Inclusion Criteria:
* Have visual acuity, using corrective lenses (no contact lenses) if necessary, in both eyes of at least +0.7 as assessed by Early Treatment of Diabetic Retinopathy Study.
* Have normal lid anatomy.
Exclusion Criteria:
* Have an abnormal biomicroscopy or ophthalmoscopy exam.
* Have a diagnosis of dry eye disease or have experienced any of the dry eye symptoms (photophobia, foreign body sensation, itching, burning, pain, dry or grittiness) in the past thirty days.
* Have used artificial tears in the past thirty days.
* Have a diagnosis of on-going ocular infection or lid margin inflammation.
* Have ever had penetrating ocular surface or intraocular surgery.
* Have a known hypersensitivity to azithromycin, or any macrolide antibiotic or to any of the ingredients in AzaSite.
* Have had a known hypersensitivity to Vigamox or any fluoroquinolone antibiotics or to any of the ingredients in Vigamox.
* Have had corneal or lid abnormalities.
* Have glaucoma, or Intra Ocular Pressure of 22 mm Hg or greater in one or both eyes.
* Have any ocular pathology with the exception of cataracts.
* Have a serious systemic disease or uncontrolled medical condition.
* Have experienced symptoms of viral or allergic conjunctivitis in the past 30 days.
* Have a history of liver or kidney disease resulting in persisting dysfunction.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00575367
Study Brief:
Protocol Section:
NCT00575367